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MiceWhile the role of 5-hydroxytryptamine (5-HT, serotonin) in the nociceptive processing has been widely
investigated in the central nervous system, information regarding its role in peripheral tissues is still lacking.
Noteworthy, 5-HT induces phenotypic changes of nociceptors and peripheral injection induces pain in
humans and nociceptive response in rodents. However, local receptors involved in 5-HT effects are not well
characterized. Thus, we aimed to investigate the role of 5-HT and some of its receptors in the peripheral
nociceptive processing in mice. Intraplantar injection of 5-HT (10, 20 or 40 μg) into the hind-paw of mice
induced paw licking behavior, which was inhibited by previous intraplantar treatment with cyproheptadine
(5-HT1 and 5-HT2 antagonist; 0.5 or 5 μg), mianserin (5-HT2 and 5-HT6 antagonist; 0.1 μg), isamoltane
(5-HT1B antagonist; 0.5 or 5 μg) and ketanserin (5-HT2A antagonist; 0.1 or 1 μg), but not by BRL 15572 (5-HT1D
antagonist; 1 or 10 μg), ondansetron (5-HT3 antagonist; 1, 5, 10 or 20 μg) and SB 269970 (5-HT7 antagonist;
2.5 and 25 μg). Altogether, these results indicate the local involvement of 5-HT1, 5-HT2 and 5-HT6, especially
5-HT1B and 5-HT2A, in the nociceptive response induced by 5-HT in mice, thus contributing to a better
understanding of 5-HT role in the peripheral nociceptive processing. In addition, they also point to important
species differences and the need of a wide evaluation of the peripheral nociceptive processing inmice as these
animals have been increasingly used in studies investigating the cellular and molecular mechanisms
mediating the nociceptive response.: +55 31 3409 6753.
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5-Hydroxytryptamine (5-HT, serotonin) is found in high concen-
trations in enterochromafﬁn cells throughout the gastrointestinal
tract and also in the central nervous system (CNS). Other important
sources are platelets (in humans), mast cells (in rodents) and
endothelial cells (Sanders-Bush and Mayer, 2006). Although 5-HT is
involved in the regulation of many physiological processes and their
malfunction, including those related to inﬂammation and pain (Hoyer
et al., 2002), the exact sites and modes of its action are still being
deﬁned.
5-HT functions have been difﬁcult to understand in part due to the
high number of receptors present in different tissues coupled to
different and sometimes opposing signal transduction systems. Signal
transduction systems and structural diversity have been used as thebasis for 5-HT receptors classiﬁcation in seven families (5-HT1 to
5-HT7). 5-HT1, 5-HT2, and 5-HT4–7 receptor families are members of
the superfamily of G protein-coupled receptors, while 5-HT3 receptor
is a ligand-gated ion channel (Barnes and Sharp, 1999; Palacios et al.,
1990).
The involvement of 5-HT in the nociceptive processing has been
investigated mainly in the CNS. The best characterized effect induced
by 5-HT is the antinociception that results from its action at the spinal
level after being released by neurons projecting from brain stem
structures (Yaksh and Tyce, 1979; Yaksh and Wilson, 1979). Many
receptors have been suggested to mediate the effect induced by 5-HT
at the spinal level, including 5-HT1, 5-HT3 and 5-HT7, among others
(Liu et al., 1988; Kiefel et al., 1992; Lin et al., 1996).
The role of 5-HT in the peripheral nociceptive processing has also
been investigated and a different proﬁle is described. 5-HT induces
phenotypic changes of nociceptors and there is wide support to its
peripheral pronociceptive role. This amine acts as an inﬂammatory
mediator that induces nociceptors sensitization (Taiwo and Levine,
1992). Peripheral injection of 5-HT induces pain in humans (Jensen
et al., 1990) and paw edema (Cole et al., 1995) and nociceptive
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addition, endogenous 5-HT is involved in the nociceptive response
induced by subcutaneous (s.c.) injection of formalin in rats (Doak and
Sawynok, 1997; Parada et al., 2001). Parada et al. (2001) demon-
strated that 48/80 compound (a mast cell depleting agent) induces
nociceptive response and cromoglycate (a mast cell degranulation
inhibitor) inhibits the second phase of the nociceptive response
induced by formalin in rats.
Different peripheral 5-HT receptors mediate the nociceptive
response induced by 5-HT. Inhibition of 5-HT nociceptive response
in rats by local injection of methysergide, ketanserin and ondansetron
(Sufka et al., 1992; Taiwo and Levine, 1992; Tokunaga et al., 1998)
indicates the involvement of 5-HT1, 5HT2 and 5HT3 receptors.
Furthermore, it has been shown that rat sensory neurons express
5-HT1B, 5-HT1D e 5-HT2A receptors (Chen et al., 1998), a result that
supports the observation that thermal or mechanical sensitization
induced by 5-HT in rats is inhibited by 5-HT1 and 5-HT2 antagonists
(Taiwo and Levine, 1992; Tokunaga et al., 1998). The involvement of
5-HT3 receptors in the peripheral nociceptive processing is also
suggested, as selective 5-HT3 antagonists inhibit nociceptive response
induced by formalin and other inﬂammatory stimuli in rats (Giordano
and Rogers, 1989; Okamoto et al., 2004).
Despite the wide knowledge about the role of 5-HT in nociception,
most studies have focused its role in the CNS, while a clear
information about its role in peripheral tissues is still lacking. In
addition, many studies have identiﬁed 5-HT receptors or their
corresponding mRNA in peripheral tissues of rats and have also
investigated the nociceptive response induced by 5-HT and its
pharmacological modulation in these animals, while such information
is scarce for mice. In this context, the aim of this study was to
investigate the role of peripheral 5-HT receptors in the nociceptive
response induced by 5-HT in mice by using antagonists that target
different receptors.2. Material and methods
2.1. Animals
Male Swiss mice (25–30 g), with free access to food and water and
maintained in a room with a 12 h light-dark cycle, were used. The
experiments were carried out at 27±1 °C, the thermoneutral zone for
rodents. During the experiments, the animals were carefully handled,
so as to result in the least behavioral stress. Intraplantar (i.pl.)
injections were performed with the animal gently restrained in a soft
piece of cloth, with the assistance of a second experimenter. Each
animal was used once, being euthanized in a CO2 chamber
immediately after the experiment. The experiments were carried
out according to ethical guidelines on animal experimentation
(Zimmermann, 1983), and approved by the Ethics Committee on
Animal Experimentation (CETEA) of the Federal University of Minas
Gerais (protocol 132/2007).Fig. 1. Paw licking behavior induced by 5-HT (2.5; 5; 10; 20 or 40 μg/10 μl; i.pl.) in mice.
*Statistical difference when compared to the group treated with vehicle, pb0.05
(n=6–7).2.2. Drugs and solutions
5-Hydroxytryptamine hydrochloride (Sigma, USA), cyproheptadine
hydrochloride (Sigma, USA; 5-HT1 and 5-HT2 receptors antagonist),
mianserin (Sigma, USA; 5-HT2 and 5-HT6 receptors antagonist), isamol-
tane hemifumarate (Tocris, USA; 5-HT1B receptors antagonist),
BRL 15572 (Sigma,USA; 5-HT1D receptors antagonist), ketanserin tartrate
(Biotrend, Switzerland; 5-HT2A receptors antagonist), ondansetron
hydrochloride (Cristália, Brazil; 5-HT3 receptors antagonist) and
SB-269970 hydrochloride (Sigma, USA; 5-HT7 receptors antagonist)
were used. All drugs, except BRL 15572,were freshly diluted in 0.9%NaCl.
BRL 15572 was diluted in dimethylsulphoxide (DMSO) 4%.2.3. Evaluation of nociceptive behavior
Nociceptive behavior was assessed after intraplantar (i.pl.) injection
of different doses of 5-HT in a volume of 10 μl into the right hind-paw of
mice. The time the animals spent licking the injected paw was
determined within 20 min. Two or three observers evaluated the
nociceptive behavior of the animals in the different experimental
protocols. The observers were not aware of the treatments and
registered the nociceptive behavior of animals from the different
experimental groups within each protocol. In preliminary experiments,
it was observed that after this period 5-HT-treated animals displayed
nociceptive behavior that does not differ from that of saline-treated
animals. To evaluate the role played by peripheral 5-HT receptors in the
nociceptive response induced by 5-HT, different antagonists were
injected ipsilaterally by the i.pl. route, in a volumeof 10 μl, 10 minbefore
5-HT injection. To investigate whether the effect induced by the
antagonists results from local or systemic actions, a contralateral-
treated group of animals was added to the protocols.
2.4. Statistical analysis
The results were expressed as mean±SEM. Comparison between
groups was assessed by one-way analysis of variance followed by
Newman–Keuls post hoc test. Differences with pb0.05 were considered
signiﬁcant.
3. Results
3.1. Paw licking behavior induced by 5-HT
I.pl. 5-HT injection inmice induced nociceptive response displayed
as paw licking behavior, which started immediately after the
injection. The doses of 2.5 and 5 μg did not induce response that
differs from that induced by vehicle. The doses ranging from 10 to
40 μg induced intense paw licking behavior in mice, and the dose of
20 μg was chosen for subsequent protocols as it seems to induce
maximal response that is not different from those induced by 10 or
40 μg of 5-HT (Fig. 1).
3.2. Effect induced by antagonists on paw licking behavior induced by 5-HT
To investigate the role played by peripheral 5-HT receptors in the
nociceptive response induced by i.pl. injection of 5-HT (20 μg) inmice,
different antagonists were injected (i.pl.) into the right hind-paw
10 min before 5-HT injection.
Previous treatment with cyproheptadine (0.5 and 5 μg; Fig. 2),
mianserin (0.1 μg; Fig. 3), isamoltane (0.5 and 5 μg; Fig. 4) and
ketanserin (0.1 and 1 μg; Fig. 5) partially inhibited paw licking
behavior induced by 5-HT. When injected into the contralateral paw
Fig. 2. Effect induced by cyproheptadine (0.5 or 5 μg; −10 min; 10 μl; i.pl.) on paw
licking behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. *Statistical difference
when compared to the group treated with vehicle, pb0.05 (n=6).
Fig. 4. Effect induced by isamoltane (0.5 or 5 μg; −10 min; 10 μl; i.pl.) on paw licking
behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. * Statistical difference when
compared to the group treated with vehicle, pb0.05 (n=6–8).
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ceptive effect, suggesting that such effect may result from inhibition of
5-HT interaction with its peripheral receptors at the site of injection.
As the 5-HT1D antagonist, BRL 15572, presents low solubility in
saline, we used DMSO 4% to prepare its solution. Fig. 6A shows that
previous (−10 min) i.pl. injection of DMSO 2 or 4% (10 μl, −10 min)
did not change the nociceptive response induced by 5-HT. Although
the nociceptive response induced by 5-HTwas clearly inhibited by the
previous antagonists, BRL 15572, at the doses used in the present
study (1 and 10 μg), was devoid of such effect (Fig. 6B).
The 5-HT3 and 5-HT7 antagonists, ondansetron (5 and 20 μg; Fig. 7)
and SB 269970 (2.5 and 25 μg; Fig. 8), respectively, also did not inhibit
the nociceptive response induced by 5-HT. Even when co-injected, the
antagonists ondansetron (1 and 10 μg) and SB 269970 (2.5 and 25 μg)
also did not inhibit the paw licking behavior induced by 5-HT in mice
(Fig. 9).
4. Discussion
Initially, we characterized the nociceptive response induced by
5-HT. I.pl. injection of this amine induced immediate paw licking
behavior, that did not last long (approximately 20 min). Among the
different experimental protocols, the magnitudes of the responses
induced by 5-HT varied. As the protocols were carried out throughout
the year, seasonal inﬂuences may be expected as these have been
documented for other nociceptive stimuli (Winters et al., 1986;
Perissin et al., 2003) and also for the antinociceptive effect induced by
drugs (Winters et al., 1986). The concentrations of 5-HT in the
injected solutions are much higher than the concentration of thisFig. 3. Effect induced by mianserin (0.05 or 0.1 μg;−10 min; 10 μl; i.pl.) on paw licking
behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. * Statistical difference when
compared to the group treated with vehicle, pb0.05 (n=10–13).amine found in the paw of rodents (Nitanda et al., 2005), raising the
possibility of unspeciﬁc effects induced by 5-HT via interaction with
targets different from the 5-HT receptors. However, the short duration
effect induced by 5-HT is highly indicative of a fast inactivation and/or
diffusion from the site of injection. Thus, the concentration of 5-HT in
the injection solution certainly does not represent the real concen-
tration of the amine in the tissue after its injection. In addition,
previous studies have also demonstrated that doses of 5-HT higher
than 30 μg are necessary to induce Fos expression in the dorsal horn
neurons or nociceptive response in rodents (Doi-Saika et al., 1997;
Parada et al., 2001; Tambeli et al., 2006; Tokunaga et al., 1998).
Several 5-HT receptors or their corresponding mRNA have been
directly identiﬁed in sensory neurons of rats, including 5-HT1A,
5-HT1B, 5-HT1D, 5-HT1F, 5-HT2A, 5-HT2C, 5-HT3, 5-HT4, 5-HT5A, 5-HT5B
and 5-HT7 (Chen et al., 1998; Sommer, 2004; Wu et al., 2001). In
addition, increased mRNA levels for many of these receptors have
been observed during inﬂammation induced by different stimuli in
rats (Liu et al., 2005; Wang et al., 2003; Wu et al., 2001). Altogether,
5-HT receptors identiﬁcation as well as increase of their expression
indicates an important role played by 5-HT in peripheral features of
inﬂammatory and nociceptive responses. Although, many studies
have identiﬁed 5-HT receptors or their corresponding mRNA in
peripheral tissues of rats, such information is scarce for mice.
Regarding 5-HT receptors function in the peripheral nociceptive
processing, many aspects remain unclear as different roles have been
attributed to different receptor subtypes. Some have attributed an
inhibitory role to 5-HT1 receptors, as i.pl. injection of 5-HT1A, 5-HT1B,
5-HT1D, 5-HT1E and 5-HT1F agonists inhibits the nociceptive response
induced by formaldehyde in rats (Granados-Soto et al., 2010). These
results are consistent with the frequently described signalFig. 5. Effect induced by ketanserin (0.1 or 1 μg; −10 min; 10 μl; i.pl.) on paw licking
behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. * Statistical difference when
compared to the group treated with vehicle, pb0.05 (n=10–13).
Fig. 6. Effect induced by DMSO (A −10 min; 10 μl; i.pl.) or BRL 15572 (B 1 or 10 μg;
−10 min; 10 μl; i.pl.) on paw licking behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in
mice. (n=4–14).
Fig. 8. Effect induced by SB 269970 (2.5 or 25 μg;−10 min; 10 μl; i.pl.) on paw licking
behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. (n=6–7).
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open potassium channels (Hannon and Hoyer, 2008; Hoyer et al.,
1994).
However, despite the evidence suggesting anantinociceptive role for
5-HT1 receptors, our results show that they also have a pro-nociceptive
role, since isamoltane, a 5-HT1B antagonist, and cyproheptadine, a 5-HT1
and5-HT2 antagonist, inhibitedpaw lickingbehavior inducedby5-HT in
mice. A peripheral role for these receptors in the response induced by
5-HT is clearly demonstrated by the lack of effect when the antagonists
were injected into the contralateral paw. Corroborating our results,
Taiwo and Levine (1992) showed that i.pl. injection of the 5-HT1AFig. 7. Effect induced by ondansetron (5 or 20 μg;−10 min; 10 μl; i.pl.) on paw licking
behavior induced by 5-HT (20 μg; 10 μl; i.pl.) in mice. (n=6–7).antagonists spiroxatrine and spiperone attenuates the hyperalgesia
inducedby i.pl. injection of 5-HT in rats.Although Sufkaet al. (1992) also
concluded that peripheral 5-HT1 receptors mediate the nociceptive
response induced by i.pl. injection of 5-HT in rats, these authors used
methysergide, a non-selective antagonist, thus limiting the association
of this receptor to the observed response.
A challenge to the pronociceptive role of 5-HT1 receptors is the
inhibitory signal transduction system coupled to their activation,
Gi/G0 proteins that open potassium channels (Hannon and Hoyer,
2008; Hoyer et al., 1994). However, these receptors may also exert an
excitatory role, since it has been found that 5-HT1B activation is
associated to inositol phosphate production and increase in intracel-
lular calcium levels, leading to vascular smooth muscle contraction
(Dickenson and Hill, 1995; Ebersole et al., 1993; Zgombick et al.,
1993). Interestingly, in our study we observed that a selective 5-HT1B
antagonist, isamoltane, inhibited the nociceptive response induced by
5-HT. Altogether, these data suggest that the molecular mechanisms
of second messengers generated upon activation of 5-HT1 receptors
may vary among different tissues and species, thus contributing to the
different results reported in the literature.
The role of 5-HT2 receptors, differently from that of 5-HT1
receptors, in the peripheral nociceptive processing seems to be
more clear-cut. We showed that ipsilateral, but not contralateral, i.pl.
injection of ketanserin, a 5-HT2A antagonist, inhibits paw licking
behavior induced by 5-HT in mice. In spite of not being as
straightforward as the effect induced by ketanserin, the effects
induced by cyproheptadine and mianserin also provide evidence forFig. 9. Effect induced by co-administration of ondansetron (1 or 10 μg) and SB 269970
(2.5 or 25 μg) (−10 min; 10 μl; i.pl.) on paw licking behavior induced by 5-HT (20 μg;
10 μl; i.pl.) in mice. (n=4–6).
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Cyproheptadine and mianserin, in addition to interacting with 5-HT2
receptors, also interact with 5-HT1 and 5-HT6 receptors, respectively.
In agreement with our results, ketanserin reduces thermal or
mechanical hyperalgesia induced by various stimuli, including 5-HT,
in rats only when applied over or injected into the ipsilateral paw
(Hong et al., 2006; Wei et al., 2005). Sarpogrelate, another 5-HT2A
receptor antagonist, also inhibits the nociceptive response induced by
formaldehyde and heat injury in rats only when administered into the
ipsilateral paw (Obata et al., 2000; Sasaki et al., 2006). Considering
that we and others have shown that the doses of ketanserin and
sarpogrelate induced an effect only after ipsilateral injection, the set of
results emphasizes the involvement of 5-HT2A receptors in peripheral
features of the investigated responses.
As the nociceptive response induced by i.pl. injection of 5-HT was
immediate, it may result from direct activation of nociceptors, with
rapid increases in membrane permeability to some ions, such as Na+
and Ca+2. Among the 5-HT receptors identiﬁed in sensory neurons
that would expectedly mediate this immediate response is the 5-HT3
receptor, an ion channel that allows rapid Na+ and Ca+2 inﬂux.
In spite of the presence of 5-HT3 in sensory neurons (Chen et al.,
1998; Sommer, 2004; Wu et al., 2001), we observed that its antagonist,
ondansetron, did not inhibit paw licking behavior induced by 5-HT in
mice. The role of 5-HT3 receptors in the peripheral nociceptive
processing is not well established. Tokunaga et al. (1998) and Oliveira
et al. (2007) showed opposite results for the same 5-HT3 antagonist,
tropisetron, when tested against the nociceptive response induced by
5-HT in rats. TaiwoandLevine (1992) showed that i.pl. injection of 5-HT,
but not of two 5-HT3 agonists (2-methyl-5-hydroxytryptamine and
phenylbiguanide), induces mechanical hyperalgesia in rats. In addition,
an increase of Fos-like immunoreactivity in the spinal cord was
observed after i.pl. injection of 5-HT and 5-HT2 agonists, but not of
5-HT3 agonists, in rats (Doi-Saika et al., 1997). These authors also
showed that ketanserin (5-HT2A antagonist), but not tropisetron,
inhibited the response induced by 5-HT. There is no reasonable
explanation for the discrepant data provided by all these studies. In
the case of 5-HT3 receptors, a species difference in the expression of this
receptor subtype on sensory neurons cannot be pointed, as opposing
results have been found even within the same species.
The role played by 5-HT7 receptors in the peripheral nociceptive
processing is even less well-known. 5-HT7 receptors have also been
identiﬁed in sensory neurons (Chen et al., 1998; Sommer, 2004;Wu et
al., 2001) and couple to a signal transduction system that results in the
increase of cAMP. Rocha-Gonzalez et al. (2005) showed that SB
269970, a 5-HT7 antagonist, inhibits nociceptive behavior induced by
formaldehyde, 5-HT or serotonergic agonists in rats. However, in our
study we observed that the nociceptive response induced by 5-HT in
mice was not inhibited by the same antagonist.
The absence of effect induced by ondansentron and SB 269970 on
the nociceptive response induced by 5-HT in mice does not rule out
the involvement of 5-HT3 and 5-HT7 receptors. One may wonder
whether higher doses of both antagonists could induce an effect
similar to that induced by other antagonists or that 5-HT3 and 5-HT7
receptors play a minor role. However, the absence of effect induced
even by the association of ondansentron and SB 269970 indicates the
absence of a peripheral role for 5-HT3 and 5-HT7 receptors in the
nociceptive response induced by 5-HT in mice or, assuming that such
a role exists, it is much reduced when compared to that of 5-HT1 and
5-HT2 receptors.
Asmany5-HT receptors have been identiﬁed in sensory neurons and
different peripheral sites, it is reasonable to assume that a single
antagonist may not abolish 5-HT-induced responses, since this amine
could interactwithmore thanone excitatory receptor. Thus, themarked
inhibition of 5-HT nociceptive response by cyproheptadine and
mianserin may be related to their non-selective binding properties,
targeting more than one receptor, which in turn contributes to a widerange effect. On the other hand, the inhibition of the nociceptive
response by the selective antagonists' isamoltane and ketanserin
indicates that 5-HT1B and 5-HT2A receptors have marked an involve-
ment in the nociceptive response induced by i.pl. 5-HT in mice, even
more important than that of other excitatory 5-HT receptors.
Some of our results differ from those reported by others who
investigated the receptors mediating the nociceptive response induced
by 5-HT. Although the use of different antagonists and different doses
may explain the divergent results, the most likely possibility is
difference between rats, used in most of the studies, and mice.
Investigation of the nociceptive processing in the mouse and inherent
species differences is warranted as its use is steadily increasing in the
recent years due mainly to the wide availability of deﬁcient and
transgenic animals (Mogil, 2009).
5. Conclusion
In conclusion, we showed that i.pl. injection of 5-HT induces paw
licking behavior in mice, which is inhibited by cyproheptadine,
mianserin, isamoltane and ketanserin. Altogether, these results
provide evidence of local involvement of 5-HT1, 5-HT2 and 5-HT6,
specially 5-HT1B and 5-HT2A, in the nociceptive response induced by
5-HT in mice, thus contributing to a better understanding of 5-HT role
in the peripheral nociceptive processing. In addition, they also point to
the need of a wide evaluation of the peripheral nociceptive processing
in mice as these animals have been increasingly used in studies
investigating the cellular and molecular mechanisms mediating the
nociceptive response.
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